Morphic Therapeutic

📍 Waltham, United States🗓 Founded 2015👥 139 employees💰 Last funded Nov 2018
Pharmaceutical Manufacturing🌐 morphictx.com
Website LinkedIn
Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohns disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention. Despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2016–2018 · investors recorded per year
201622017120181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Morphic Therapeutic?
Morphic Therapeutic has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Morphic Therapeutic last raise funding?
The most recent investment in Morphic Therapeutic recorded on gritt.io was in November 2018.
When was Morphic Therapeutic founded?
Morphic Therapeutic was founded in 2015.
What industry is Morphic Therapeutic in?
Morphic Therapeutic operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Morphic Therapeutic based?
Morphic Therapeutic is headquartered in Waltham, United States.